Even though the hold up to completing deal regarding Elto Pharma with EMOR is Psychogenics, if AMBS can get some upfront cash for the deal would be a huge boost and inline with expectation of most of shareholders.
Expecting $.03 by the end of the week.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links